Toll-like receptors types 2 and 6 and the apoptotic process in human neutrophils

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 2, 2006, Pages 137-142

  Jabłońska, Ewa ^a   Marcińczyk, Magdalena ^a   Jabłoński, Jakub ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; fMLP; IL 18; Neutrophils (PMNs); TLR2; TLR6

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; RECOMBINANT INTERLEUKIN 18; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ADULT; APOPTOSIS; ARTICLE; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NORMAL HUMAN; PROTEIN EXPRESSION;

ADULT; APOPTOSIS; CELLS, CULTURED; HUMANS; INTERLEUKIN-18; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 33747501436     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0014-2     Document Type: Article

References (28)

1. Aleman M., Schierloh P., de la Barrera S.S., Musella R.M., Saab M.A., Baldini M., Abbate E. and Sasiain M.C. (2004): Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving Toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect. Immun., 72, 5150-5158.
2. Aliprantis A. O., Yang R. B., Weiss D. S., Godowski P. and Zychlinsky A. (2000): The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J., 19, 3325-3336.
3. Brach M. A., deVos S., Gruss H. J. and Herrmann F. (1992): Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood, 80, 2920-2924.
4. Colotta F., Re F., Polentarutti N., Sozzani S. and Mantovani A. (1992): Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020.
5. Flo T. H., Halaas O., Torp S., Ryan L., Lien E., Dybdahl B., Sundan A. and Espevik T. (2001): Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol., 69, 474-481.
6. Fol M. (2003): Interleukin-18. Postepy Hig. Med. Dośw., 57, 685-699.
7. Francois S., El Benna J., Dang P. M., Pedruzzi E., Gougerot-Pocidalo M. A. and Elbim C. (2005). Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-κB signalling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol., 174, 3633-3642.
8. Fulop T. Jr., Fouquet C., Allaire P., Perrin N., Lacombe G., Stankova J., Rola-Pleszczynski M., Gagne D., Wagner J. R., Khalil A. and Dupuis G. (1997): Changes in apoptosis of human polymorphonuclear granulocytes with aging. Mech. Ageing Dev., 96, 15-34.
9. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J. and Wilson C.B. (2001): Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol., 166, 15-19.
10. Hayashi F., Means T. K. and Luster A. D. (2003): Toll-like receptors stimulate human neutrophil function. Blood, 102, 2660-2669.
11. Hu T. H., Bei L., Huang Y. F. and Shen X. (1999): The relationship between fMLP induced neutrophil respiratory burst and the apoptosis of neutrophil. Shi Yan Sheng Wu Xue Bao, 32, 359-366.
12. Into T., Kiura K., Yasuda M., Kataoka H., Inoue N., Hasebe A., Takeda K., Akira S. and Shibata K. (2004): Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell. Microbiol., 6, 187-199.
13. Into T., Nodasaka Y., Hasebe A., Okuzawa T., Nakamura J., Ohata N. and Shibata K. (2002): Mycoplasmal lipoproteins induce Toll-like receptor 2- and caspases-mediated cell death in lymphocytes and monocytes. Microbiol. Immunol., 46, 265-276.
14. Klein J. B., Buridi A., Coxon P. Y., Rane M. J., Manning T., Kettritz R. and McLeish K. R. (2001): Role of extracellular signal-regulated kinase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis. Cell Signal., 13, 335-343.
15. Kurt-Jones E. A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P. E. and Finberg R. W. (2002): Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood, 100, 1860-1868.
16. Lee A., Whyte M. K. and Haslett C. (1993): Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol., 54, 283-288.
17. Lee S. Y., Oh J. Y., Lee M. J., Jang M. J., Park H. Y., Kim J. W., Min do S., Park Y. M., Chang Y. C., Bae Y. S. and Kwak J. Y. (2004). Anti-apoptotic mechanism and reduced expression of phospholipase D in spontaneous and Fas-stimulated apoptosis of human neutrophils. Eur. J. Immunol., 34, 2760-2770.
18. Lee T. H., Horton C. E., Kyan-Aung U., Haskard D., Crea A. E. and Spur B. W. (1989): Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L- phenylalanine. Clin. Sci., 77, 195-203.
19. Leung B. P., Culshaw S., Gracie J. A., Hunter D., Canetti C. A., Campbell C., Cunha F., Liew F. Y. and Mclnnes I. B. (2001): A role for IL-18 in neutrophil activation. J. Immunol., 167, 2879-2886.
20. Marcińczyk M., Jabłońska E., Pużewska W. and Hermanowska-Szpakowicz T. (2005): Effect of rhIL-15 on TLR2 expression and apoptosis of PMN from patients with Lyme disease. Med. Dosw. Mikrobiol., 57, 85-91.
21. Marino E. and Cardier J. E. (2003): Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95). Cytokine, 22, 142-148.
22. Muzio M., Polentarutti N., Bosisio D., Manoj Kumar P. P. and Mantovani A. (2000): Toll-like receptor family and signalling pathway. Biochem. Soc. Trans., 28, 563-566.
23. Ozinsky A., Smith K. D., Hume D. and Underhill D. M. (2000): Co-operative induction of pro-inflammatory signaling by Toll-like receptors. J. Endotoxin Res., 6, 393-396.
24. Parker L. C., Whyte M. K., Dower S. K. and Sabroe I. (2005): The expression and role of Toll-like receptors in the biology of the human neutrophil. J. Leukoc. Biol., 77, 886-892.
25. Sabroe I., Prince L. R., Jones E. C., Horsburgh M. J., Foster S. J., Vogel S. N., Dower S. K. and Whyte M. K. (2003): Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol., 170, 5268-5275.
26. Yoon D. Y., Cho Y. S., Park J. W., Kim S. H. and Kim J. W (2004): Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor. Clin. Chem. Lab. Med., 42, 499-506.
27. Zhang D., Zhang G., Hayden M. S., Greenblatt M. B., Bussey C., Flavell R. A. and Ghosh S. (2004): A Toll-like receptor that prevents infection by uropathogenic bacteria. Science, 303, 1522-1526.
28. Zhang Y. and Bliska J. B. (2003): Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect. Immun., 71, 1513-1519.